View Article

Abstract

Ethosome based formulations represent an advanced transdermal drug delivery system designed to enhance skin penetration and therapeutic efficacy. In this study, an ethosomal cream containing papain, a proteolytic enzyme, and curcumin, a natural anti-inflammatory and anti-oxidant compound, was developed for the management of psoriasis. Papain facilitates the removal of hyperkeratotic plaques, while curcumin modulates inflammatory pathways and oxidative stress associated with psoriatic lesions. The ethosomal carrier improves the permeation of these bioactive agents through the stratum corneum, ensuring targeted delivery to affected skin layers. The cream was characterized for physicochemical properties, stability, entrapment efficiency results demonstrated enhanced drug penetration, sustained release, and potential synergistic effects of papain and curcumin, suggesting that the ethosomal cream could serve as a promising non-invasive therapeutic approach for psoriasis with improved efficacy and reduced systemic side effects.

Keywords

Ethosome, Entrapment efficiency, Phospholipid, Psoriasis, Strateum corneum, Topical Drug Delivery

Introduction

The new pharmaceutical forms with optimized properties, such as reduced particle size, enhanced permeability parameters, and targeted site delivery, is referred to as novel drug delivery system (NDDS). When compared to their performance in conventional dosage forms, NDDS can increase the efficacy of biotherapeutic agents. It enhances therapeutic efficacy and improves patient compliance. These systems utilize innovative carriers such as nanoparticle, liposomes, ethosomes, and niosomes to achieve sustained release, improved stability, and site-specific action.

Newer lipid vesicular carriers are called ethosomes. Ethosomes are non-invasive drug delivery methods that facilitate deeper drug molecular penetration into the skin or circulation. They contain a significant quantity of alcohol. These nanocarriers carry medicinal substances with a variety of physicochemical characteristics through the skin and into the dermis deeper layers. They have several applications as drug carriers to improve the dermal and transdermal drug delivery of several drugs. They are soft, flexible vesicles designed to more effectively transport active substances. Phospholipids, water, and alcohol in comparatively larger concentrations make up the majority of ethosomes. Both fat-soluble and water-soluble medications are better absorbed thanks to their bilayer structure, which contains both fat and water. Higher ethanol concentrations (30–45%) offer stability, allowing the drug to permeate deeper and outer layers of the skin, increasing absorption via the skin.

Figure no. 1: Structure of ethosome

The skin is the largest organ in the body, covering its entire external surface. It also known as cutaneous membrane or the integumentary system. Skin protects our body from germs and regulates body temperature. Nerves in the skin help us to feel sensation like hot and cold.    The skin has 3 layers—the epidermis, dermis, and hypodermis.

Psoriasis, a chronic recurrent skin condition. It is distinguished by the existence of inflammatory skin lesions, such as of itchy, reddish, scaly plaques. Patients physical and mental well-being may be severely impacted by this illness. The most prevalent clinical form of psoriasis is plaque psoriasis, which appears as distinct lesions with underlying erythema and silvery scales. These lesions are typically found in places like as the lumbar area, scalp, knees, and elbows. But psoriasis can affect any area of the body, including the genitalia, nails, palms, and soles of the feet. When psoriasis is mild to severe, topical treatments which are applied directly to skin lesions are frequently utilized.

Topical delivery can be defined as the application of a drug containing formulation to the skin to directly treat cutaneous disorders for local or systemic effects. Creams, ointments, gels, patches, and sprays are examples of topical drug delivery systems that are intended to maximize medication absorption and penetration into the targeted tissues. Local skin infections are frequently treated with these methods. Formulations come in a variety of forms, including liquid, semi-solid, and solid. Creams are preferred as topical formulations due to their ease of application, good spreadability, and prolonged residence time. Incorporation of ethosomes into cream bases further enhances drug permeation, drug stability, and controlled release.

For mild-to-moderate cases of psoriasis, herbal medicine can be used as an auxiliary or supplemental therapy. Papaya contains papain (proteolytic enzyme) it reduces inflammation, exfoliating dead skin cells, reduces cell proliferation. These have anti-inflammatory, antioxidant, and antiproliferative qualities that help to reduce redness, scaling, and itching. Incorporating papaya extract into a ethosomal cream offers a enhanced skin penetration and therapeutic effectiveness in the treatment of psoriasis.

MATERIALS AND EXCIPIENTS            

All materials and excipients used in the study were of analytical grade and were obtained from standard commercial supplements. Soya lecithin were obtained from Amitex Agro Product Pvt. Ltd., Papaya were sourced from Native of  Natural, Ahmedabad, Gujarat, India., Propylene glycol, Bees wax white, Cetyl alcohol, Ethanol were obtained from Isochem laboratories, Stearic acid were sourced from  Nice chemicals(P) LTD.

FORMULATION OF ETHOSOMAL HERBAL CREAM FOR PSORIASIS

The formulation of ethosome was prepared using hot method. Preparation of ethosome and cream is further demonstrated.

Extraction of papain from papaya powder

Weigh a quantity of powder and transfer it into a conical flask and add 100ml of distilled water.

Stir well using a glass rod. Cover the conical flask and allow the mixture to stand for 12-24 hours. Keep it low temperature to prevent enzyme denaturation. Stir occasionally. After maceration, filter the mixture using a filter paper. Collect the filtrate in a conical flask. The filtrate obtained contains crude papain enzyme.

Table no. 1 Tests for papain

Sr. No

Experiment

Observation

Inference

1.

 

 

 

2.

Proteolytic Activity: Take 2-3ml of gelatin solution in a test tube. Add a small amount of papain solution. Incubate at 370C for 10-15 min. Add a few drops of trichloroacetic acid to precipitate undigested protein.

Biuret Test: Add 1-2ml of papain solution to a test tube.

Add a few drops of biuret

Reagent.

The solution remains clear

 

 

Appearance of violet colour

Presence of papain

 

 

Confirms the protein nature of papain

Figure no. 2: Extraction of papain

Method of preparation of ethosome

Hot method: The drug is combined with ethanol and propylene glycol using a hot process. A Phospholipid the dispersion is created in water at a temperature of 40OC. This dispersion is combined with previously prepared mixture. Following this, the final mixture is heated to 30OC, after which size reduction is accomplished through sonication or extrusion.

Figure no.3: Formulations of ethosome

Table no. 2 Formulation of ethosome

Sr. No

Ingredients

Weight taken

F1

F2

F3

F4

F5

F6

1.

Soya lecithin (mg)

0.2

0.3

0.4

0.5

0.6

0.8

2.

Ethanol (ml)

31

31

31

31

31

31

3.

Propylene glycol (ml)

1

1

1

1

1

1

4.

Drug (g)

1

1

1

1

1

1

5.

Distilled water

17

17

17

17

17

17

Method of preparation of herbal cream

Table no. 3 List of oil phase and aqueous phase

Part A (Oil Phase)

Part B (Aqueous Phase)

Stearic Acid

Curcumin

Beeswax

Triethanolamine

Cetyl Alcohol

Propylene Glycol

Mineral oil

Glycerine

 

Sodium benzoate

Methyl paraben

Propyl paraben

Oil in water (O/W) emulsion- based cream was formulated. The emulsifier and other oil soluble components (Part A) were dissolved in oil phase and heated to 75oC. The preservatives and other water-soluble components (Part A) were dissolved in aqueous phase and heated to 75oC. After heating, the oil phase was added in portions to the aqueous phase with continuous stirring.

Table no.4: Formulation of cream

Sr. No

Ingredients

F1

F2

F3

F4

1

Curcumin

1g

1g

1g

1g

2

Triethanolamine

1g

1g

2g

2g

3

Propylene glycol

2ml

2ml

2ml

2ml

4

Glycerin

1.5ml

2ml

3ml

3.3ml

5

Beeswax

2g

2.2g

2.5g

2.3g

6

Cetyl alcohol

3.2g

3.3g

3.5g

3.5g

7

Stearic acid

5g

5.3g

5.5g

5g

8

Methyl paraben

qs

qs

qs

qs

9

Distilled water

qs

qs

qs

qs

EVALUATION

Evaluation of Ethosome

  • Particle size

The vesicular size of the ethosomal system can be assessed using dynamic light scattering (DLS), with sizes ranging from nanometers to microns, influenced by the formulation's composition. For instance, ethosomes made with 30% ethanol and 2% phospholipid (PL) demonstrated a narrow particle size distribution, averaging 153 ± 4 nm. As the ethanol concentration decreased from 20% to 45%, vesicle size increased, with the largest particles at 20% ethanol and the smallest at 45% ethanol. The relationship between vesicle size and phospholipid content was evaluated for ethosomes containing 30% ethanol and PL concentrations from 0.5% to 4%. It was observed that ethosome size shows limited dependence on phospholipid concentration. An increase in phospholipid concentration from 0.5% to 4% led to a twofold increase in ethosome size, from 118 ± 2 nm to 249 ± 24 nm

  • Zeta potential

Zeta potential was measured using a zetasizer. The measurements were conducted on the same sample used for size analysis. Zeta potential reflects the level of repulsion between similarly charged particles in a dispersion system.

  • Entrapment efficiency

The entrapment efficiency of the ethosomal formulations was determined using an indirect method. The formulations were centrifuged at 5,000 rpm and 4°C for 30 minutes to separate unentrapped drug. The supernatant was collected, and the vesicles were washed with double distilled water and centrifuged again. The combined supernatants were diluted with ethanol, filtered, and analysed using a UV-visible spectrophotometer.

Entrapment efficiency (EE %) = (Amount of entrapped drug ÷ Total amount of drug added) x 100

 Evaluation of cream

  • Organoleptic evaluation : It involves the assessment of sensory characteristics such as colour, odour, appearance and texture of the formulation.
  • pH of the cream: The pH of the cream can be estimated on a standard digital pH meter at room temperature by taking few amount of the formulation diluted with a suitable solvent using an appropriate beaker.
  • Viscosity: Viscosity refers to the thickness or consistency of a cream, and it can affect how the cream spreads on the skin, how easily it is absorbed, and how long it stays on the skin. For psoriasis patients, cream with a higher viscosity may be more effective as they tend to stay on the skin longer and provide a more prolonged therapeutic effect. However, creams that are too thick or sticky may be difficult to apply and may cause discomfort or irritation. On the other hand, creams with a lower viscosity may be easier to apply and absorb quickly in to the skin, but they may not provide as long-lasting relief as thicker creams. Viscosity of the formulation was determined by Brookfield Viscometer at 100 rpm.
  • Homogenity: The formulations were evaluated for homogeneity based on visual appearance and texture.
  • Spreadability: The cream base should spread easily with minimal resistance and should not create excessive friction during application.
  • Procedure: An excess sample was positioned between the two glass slides, and a 100g weight was applied on top of the glass slide for 5min to compress the sample to a uniform thickness. A weight of 250g was added to the pan. The time in seconds required to separate the two slides was recorded as a measure of spreadability.
  • Washability: The cream was applied to the hand and rinsed under running water. Observations were made to determine whether the cream was easily washed away.
  • Irritancy Test: The cream was examined, for the irritancy study, a 1 sq. cm area was marked on the left dorsal surface. The cream was applied to this area, and the time was recorded. Irritancy, erythema, and oedema were monitored at regular intervals up to 24 hours and documented.

RESULT AND DISCUSSION

Particle size

Particle size was determined by using particle size analyser. The formulation (F5) is best among rest of the formulation due to optimal particle size 482.4nm and uniform vesicle distribution, indicating stable ethosome formulation. A decrease in particle size enhances stability, skin penetration, and drug release, whereas an increase in particle size may lead to vesicle aggregation, reduced uniformity and poor formulation stability. Therefore, the balanced particle size observed in formulation (F5) was represented in Figure no. 4

Figure no. 4: Particle size of Ethosome (F5)

Zeta potential

Zeta potential of F5 show adequate negative zeta potential value (-20.8), indicating sufficient electrostatic repulsion between vesicles and thus better physical stability compared to the other formulations. Zeta potential of the formulation (F5) was represented in Figure no. 5

Figure no. 5: Zeta potential of ethosome (F5)

Entrapment efficiency

Entrapment efficiency of the formulation (F5) was found to be 91%

Table no.5: Entrapment efficiency of the formulations

Formulations

Entrapment efficiency(%)

F1

89

F2

85

F3

77

F4

80

F5

91

F6

82

Organoleptic properties

The organoleptic evaluation showed that the prepared ethosomal cream possessed an acceptable colour, odour, appearance and texture.  F3 formulation indicate good consumer acceptability, compatibility of the formulation.

pH 

The pH of the formulations was determined by using digital pH meter. The pH of the ethosomal cream (F3) is in range of 4-6 which is compatible to the skin. A bar diagram Figure no. 6 was plotted by taking formulation on x-axis and pH value on y- axis with the data obtained from the Table no: 6

Table no. 6 pH of ethosomal cream

Formulation

pH

F1

3.2

F2

3.5

F3

4.8

F4

4

Figure no.6: pH of different formulation

Viscosity

The formulation (F3) was considered better than the other formulation. It exhibited optimum viscosity ensures good spreadability, ease of application and adequate retention at the site of application. Viscosity of the formulation was demonstrated in Figure no. 7.

Table no. 7: Viscosity of the cream

Formulation

Viscosity(cp)

F1

39476

F2

36422

F3

56894

F4

27665

Figure no.7: Viscosity of different formulations

Homogenity

The formulation (F3) was found to have good homogeneity, others (F1, F2, F4) have satisfactory.

Spreadability

The spreadability study revealed that all ethosomal cream formulations (F1, F2, F4) exhibited satisfactory spreadability, indicating ease of application, with formulation F3 showing comparatively higher spreadability due to its optimum viscosity and uniform cream consistency.

Table no.8: Spreadability of ethosomal cream

Formulation

Spreadability (g.cm/sec)

F1

4

F2

4.4

F3

5.7

F4

4.1

Washability

The washability test demonstrated that all ethosomal cream formulations were easily washable with water, indicating good patient compliance and the absence of excessive greasiness, which is desirable for topical application.

Irritancy

The irritancy study showed that none of the ethosomal cream formulations produced irritation at the site of application, indicating that the formulations were non-irritant and safe for topical use.

CONCLUSION

The ethosomal cream formulation demonstrates significant potential as an effective topical therapy for psoriasis by enhancing drug penetration through the stratum corneum via ethanol enriched lipid vesicles, leading to improved drug deposition at the target site, better therapeutic efficacy, reduced drug concentration and dosing frequency, and minimized local and systemic side effects compared with conventional topical therapies. Among the formulations evaluated, F3 was identified as the most suitable cream base due to its optimal consistency, spreadability, and stability, making it appropriate for topical application, while E5 emerged as the best ethosomal formulation with desirable vesicle characteristics, high entrapment efficiency, and effective drug release and permeation properties; incorporation of the optimized E5 ethosomes into the F3 cream base resulted in a stable and effective ethosomal cream formulation, overall representing a promising and patient-compliant approach for psoriasis management.   

REFERENCES

  1. Pandey S, Rajput H. A Review article on novel drug delivery system. Journal of Research in Pharmaceutical Science. 2024 April;10(4):21-31 
  2. Chauhan N, Vasava P, Khan S L, Siddiqui F A, Islam F, Chopra H, Emran T B.  Ethosomes: A novel drug carrier. 2022 Sep 8;82:104595. 
  3. Tadwee I K, Gore S, Giradkar P.  A Review: Advances in Topical Drug Delivery System. International Journal of Pharmaceutical Research and Allied Science. 2011;1(1):14-23. 
  4. Patel P R, Patel A K, Patel V M. A Review on Topical Drug Delivery System Patches. International Journal of  Pharmaceutical Science and Application. 2022;7(1):292-302. 
  5. Singh D, Mital N, Kaur G. Topical Drug Delivery Systems: A Patent Review. Expert Opinion on Therapeutic Patents. 2015;1(1):1-15. 
  6. Bani K S, Bhardwaj K. Topical drug delivery therapeutics, Drug absorption and Penetration enhancement techniques. Journal of Drug Delivery and Therapeutics. 2021;11(4):105-110. 
  7. Skin (2023, August 25). Cleveland Clinic. 
  8. Lotfollahi Z. The anatomy, physiology and function of all skin layers and the impact of             ageing on the skin. 2024;32(1):6-10. 
  9. Lalita C, Shalini G. Creams: A Review on classification, Preparation methods, Evaluation and its applications. Journal of Drug Delivery and Therapeutics. 2020;10(5s):281-289. 
  10. Sankarabhavani M, Naveena C, Nagamani P, Sowmya B. Formulation and evaluation of          herbal face cream. International Journal of Pharmaceutical Sciences Review and Research. 2023;83(2):74-78. 
  11. Sahu T, Patel T, Sahu S, Gidwani B. Skin Cream as Topical Drug Delivery System: A Review. Journal of Pharmaceutical and Biological Sciences.2016;4(5):149-154.  
  12. Singh O, Rahman M, Yashika, Kaur M. A Review on Psoriasis. 2022;20(16):5786-5793   
  13. Psoriasis:Causes. American Academy of Dermatology.   
  14. Patil P, Padalkar P, Pawar B, Surwase A, Jadhav A. A Review on Psoriasis: Types, Development, Mechanism and Precautions. 2023;(1):87-92   
  15. Verma P, Pathak K. Therapeutic and cosmeceutical potential of ethosomes: An overview. 2010;1(3):274-282   
  16. Nandure P H, Puranik P, Giram P, Lone V. Ethosome: A Novel Drug Carrier. International Journal of Pharmaceutical Research and Allied Sciences. 2013;2(3):18-30   
  17. Manpreet, Sachdeva S, Kaur H, Garg R, Singh J. Etosomes: A Revolutionary Approach in Advanced Drug Delivery Systems. Journal of Drug Delivery and Therapeutics. 2025;15(2):186-192   
  18. Jadhav P U, Gujare G S, Shende A M. Ethosomes: A Novel Tool for Vesicular Drug Delivery. Asian Journal of Pharmaceutical Research. 2024;14(1):45 
  19. Ganesh G N K, Radhakrishnan K. A Review on Ethosomes for Transdermal Applications. Research Journal of Pharmacy and Technology. 2019;12(7):3133-3143   
  20. Anitha B, Raghu N, Gopenath TS, Karthikeyan M. Medicinal uses of Carica papaya. J  Nat Ayurvedic Medicines. 2018;2(6):1-11. 
  21. Pawar H, Karde M, Mundle N, Jadhav P, Mehra K. Phytochemical evaluation and      Curcumin content determination of turmeric rhizomes collected from bhandara district of Maharashtra (India). Med Chem. 2014;4(8):588-9. 
  22. Zhen Z, Xi TF, Zheng YF. Surface modification by natural biopolymer coatings oz Magnesium alloys for biomedical applications. In: Sankara Narayanan TSN, Park I-S, Lee M-H, editors. Surface Modification of Magnesium and its Alloys for Biomedical Applications. Cambridge: Woodhead Publishing;2015. P.301-333.

Reference

  1. Pandey S, Rajput H. A Review article on novel drug delivery system. Journal of Research in Pharmaceutical Science. 2024 April;10(4):21-31 
  2. Chauhan N, Vasava P, Khan S L, Siddiqui F A, Islam F, Chopra H, Emran T B.  Ethosomes: A novel drug carrier. 2022 Sep 8;82:104595. 
  3. Tadwee I K, Gore S, Giradkar P.  A Review: Advances in Topical Drug Delivery System. International Journal of Pharmaceutical Research and Allied Science. 2011;1(1):14-23. 
  4. Patel P R, Patel A K, Patel V M. A Review on Topical Drug Delivery System Patches. International Journal of  Pharmaceutical Science and Application. 2022;7(1):292-302. 
  5. Singh D, Mital N, Kaur G. Topical Drug Delivery Systems: A Patent Review. Expert Opinion on Therapeutic Patents. 2015;1(1):1-15. 
  6. Bani K S, Bhardwaj K. Topical drug delivery therapeutics, Drug absorption and Penetration enhancement techniques. Journal of Drug Delivery and Therapeutics. 2021;11(4):105-110. 
  7. Skin (2023, August 25). Cleveland Clinic. 
  8. Lotfollahi Z. The anatomy, physiology and function of all skin layers and the impact of             ageing on the skin. 2024;32(1):6-10. 
  9. Lalita C, Shalini G. Creams: A Review on classification, Preparation methods, Evaluation and its applications. Journal of Drug Delivery and Therapeutics. 2020;10(5s):281-289. 
  10. Sankarabhavani M, Naveena C, Nagamani P, Sowmya B. Formulation and evaluation of          herbal face cream. International Journal of Pharmaceutical Sciences Review and Research. 2023;83(2):74-78. 
  11. Sahu T, Patel T, Sahu S, Gidwani B. Skin Cream as Topical Drug Delivery System: A Review. Journal of Pharmaceutical and Biological Sciences.2016;4(5):149-154.  
  12. Singh O, Rahman M, Yashika, Kaur M. A Review on Psoriasis. 2022;20(16):5786-5793   
  13. Psoriasis:Causes. American Academy of Dermatology.   
  14. Patil P, Padalkar P, Pawar B, Surwase A, Jadhav A. A Review on Psoriasis: Types, Development, Mechanism and Precautions. 2023;(1):87-92   
  15. Verma P, Pathak K. Therapeutic and cosmeceutical potential of ethosomes: An overview. 2010;1(3):274-282   
  16. Nandure P H, Puranik P, Giram P, Lone V. Ethosome: A Novel Drug Carrier. International Journal of Pharmaceutical Research and Allied Sciences. 2013;2(3):18-30   
  17. Manpreet, Sachdeva S, Kaur H, Garg R, Singh J. Etosomes: A Revolutionary Approach in Advanced Drug Delivery Systems. Journal of Drug Delivery and Therapeutics. 2025;15(2):186-192   
  18. Jadhav P U, Gujare G S, Shende A M. Ethosomes: A Novel Tool for Vesicular Drug Delivery. Asian Journal of Pharmaceutical Research. 2024;14(1):45 
  19. Ganesh G N K, Radhakrishnan K. A Review on Ethosomes for Transdermal Applications. Research Journal of Pharmacy and Technology. 2019;12(7):3133-3143   
  20. Anitha B, Raghu N, Gopenath TS, Karthikeyan M. Medicinal uses of Carica papaya. J  Nat Ayurvedic Medicines. 2018;2(6):1-11. 
  21. Pawar H, Karde M, Mundle N, Jadhav P, Mehra K. Phytochemical evaluation and      Curcumin content determination of turmeric rhizomes collected from bhandara district of Maharashtra (India). Med Chem. 2014;4(8):588-9. 
  22. Zhen Z, Xi TF, Zheng YF. Surface modification by natural biopolymer coatings oz Magnesium alloys for biomedical applications. In: Sankara Narayanan TSN, Park I-S, Lee M-H, editors. Surface Modification of Magnesium and its Alloys for Biomedical Applications. Cambridge: Woodhead Publishing;2015. P.301-333.

Photo
R. Rifana Fathima
Corresponding author

Mount Zion College of Pharmaceutical Sciences and Research, Adoor

Photo
Jeena Sara Reji
Co-author

Mount Zion College of Pharmaceutical Sciences and Research, Adoor

Photo
Ashna N
Co-author

Mount Zion College of Pharmaceutical Sciences and Research, Adoor

Photo
Ashly Elizabeth Biju
Co-author

Mount Zion College of Pharmaceutical Sciences and Research, Adoor

Photo
Noora N
Co-author

Mount Zion College of Pharmaceutical Sciences and Research, Adoor

Photo
Dr. Bhageerathy A
Co-author

Mount Zion College of Pharmaceutical Sciences and Research, Adoor

R. Rifana Fathima, Jeena Sara Reji, Ashna N, Ashly Elizabeth Biju, Noora N, Dr. Bhageerathy A, Herbal Ethosomal Cream for Psoriasis, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 2, 1334-1342. https://doi.org/10.5281/zenodo.18551440

More related articles
Integration of Artificial Intelligence (AI) in Una...
Anjum Ali Qadri, Ziyaul Mustafa, Mohd Noman Taha, Abdullah, ...
A Review on Formulation and Evaluation of BI- Laye...
Salve Bhumika, Zanjad Aniket, Kalamkar Tejas, Deshmukh Komal, ...
Study The Efficacy of Polyherbal Formulations (Vet...
Dr. Sushma Ghadigaonkar, Purva Joshi, M. G. Ghadigaonkar , ...
Development and Validation of a Stability-Indicating RP-HPLC Method for the Quan...
Mukesh Patil, Raj Patil, Ashish Jain, Swati Borase, Rupali Bothara, ...
Formulation, Characterization, And Evaluation of Betel Leaf Jelly for Oral Admin...
Prachi Pote, Aakanksha Bhoi, Hemangi Shinde, Priyanka Marathe, Kishor Rathi, Dr. Ravindra Rohidas Pa...
Related Articles
Evaluation and Comparative Study of Formulated, Branded & Generic Linagliptin Ta...
Suvarna Kasi, R. Malliswari, Dr. B. Nagamani, K. Bhavana, G. Sai Lakshmi, R. Lalitha, B. Nikhil Sai,...
Formulation And Evaluation of Ophthalmic in Situ Gel for Treatment of Fungal Ker...
Gourav Babriwal, Rahul Meena, Rashmi Mishra, Radheshyam Vishvakarma, Aarti Nandwana, Rajat Pawar, ...
Integration of Artificial Intelligence (AI) in Unani Medicine: Pathways for Diag...
Anjum Ali Qadri, Ziyaul Mustafa, Mohd Noman Taha, Abdullah, ...
More related articles
Integration of Artificial Intelligence (AI) in Unani Medicine: Pathways for Diag...
Anjum Ali Qadri, Ziyaul Mustafa, Mohd Noman Taha, Abdullah, ...
A Review on Formulation and Evaluation of BI- Layered Tablet of Divalproex Sodiu...
Salve Bhumika, Zanjad Aniket, Kalamkar Tejas, Deshmukh Komal, ...
Study The Efficacy of Polyherbal Formulations (Vetricare Integumentary) Against ...
Dr. Sushma Ghadigaonkar, Purva Joshi, M. G. Ghadigaonkar , ...
Integration of Artificial Intelligence (AI) in Unani Medicine: Pathways for Diag...
Anjum Ali Qadri, Ziyaul Mustafa, Mohd Noman Taha, Abdullah, ...
A Review on Formulation and Evaluation of BI- Layered Tablet of Divalproex Sodiu...
Salve Bhumika, Zanjad Aniket, Kalamkar Tejas, Deshmukh Komal, ...
Study The Efficacy of Polyherbal Formulations (Vetricare Integumentary) Against ...
Dr. Sushma Ghadigaonkar, Purva Joshi, M. G. Ghadigaonkar , ...